MedPath

The Effects of Anodal Stimulation on Echocardiographic Outcome in Patients With Cardiac Resynchronization Therapy

Not Applicable
Conditions
Heart Failure
Interventions
Device: Triple site pacing mode
Registration Number
NCT00825006
Lead Sponsor
Sheba Medical Center
Brief Summary

To investigate the hemodynamic, inter and intraventricular desynchrony effects of anodal stimulation and triple site pacing compared with the usual dual site pacing by echocardiography and Tissue Doppler Imaging.

Detailed Description

Thirty patients who underwent CRT and had evidence of anodal stimulation will be included in the study. All patients undergo a conventional echocardiography after 10 minutes of continuous triple site pacing and after 10 minutes of continuous dual site pacing (Customary biventricular pacing).Echocardiography studies will be performed to measure dP/dT using continuous flow Doppler velocity profiles of mitral regurgitation, LV volumes and Left ventricular ejection fraction. Left intraventricular desynchrony is assessed by using TDI.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients with biventricular pacemakers who met currently accepted indications for CRT, including dilated cardiomyopathy with LV ejection fraction < 35% (ischemic and nonischemic etiologies) with New York Heart Association class III to IV congestive heart failure and QRS duration > 120 ms.
Exclusion Criteria
  • Patients with first generation CRT device
  • Integrated bipolar defibrillator device
  • Atrial fibrillation during the screening phase
  • Patients who cannot tolerate triple site pacing for several minutes (i.e diaphragmatic pacing)
  • Patients with epicardial LV leads
  • Patients with LV leads located out of the lateral or posterolateral areas

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Triple site pacingTriple site pacing modeTriple site pacing(LV tip electrode,RV tip electrode and RV ring electrode)
Primary Outcome Measures
NameTimeMethod
Myocardial Performance Index, dP/dTAfter 10 minutes of triple site pacing and 10 minutes of dual sute pacing
Secondary Outcome Measures
NameTimeMethod
Inter and intraventricular dyssynchrony parameters, LV volumes, LVEFAfter 10 minutes of triple site pacing and 10 minutes of dual site pacing

Trial Locations

Locations (1)

Heart Institute, Sheba Medical Center

🇮🇱

Tel Hashomer, Israel

© Copyright 2025. All Rights Reserved by MedPath